BlueRock Therapeutics

BlueRock Therapeutics

Biotechnology Research

Cambridge, Massachusetts 65,359 followers

Striving to transform the treatment of disease by harnessing the power of cell therapy

About us

BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform harnesses the power of cells to create new medicines for neurology, cardiology, and immunology indications. BlueRock Therapeutics’ cell differentiation technology recapitulates the cell’s developmental biology to produce authentic cell therapies, which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. BlueRock’s culture is defined by scientific innovation, the highest ethical standards and an urgency to bring transformative treatments to all who would benefit. The company strives to be a top employer of scientific talent, empowering every member of the team to make meaningful and lasting contributions to the burgeoning field of regenerative medicine. Become a BlueRocker! We are expanding our BlueRock team at all locations. Contact us via LinkedIn or our website to learn about rewarding career opportunities.

Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
Cambridge, Massachusetts
Type
Privately Held
Founded
2016
Specialties
Stem Cell Therapeutics, Engineered Cell Therapy, Cardiology, Neurology, Immunology, Regenerative Medicine, and Cell+Gene

Locations

Employees at BlueRock Therapeutics

Updates

Similar pages

Browse jobs

Funding